Skip to content

Assembly Biosciences, Inc.

ASMB· NasdaqCore metricsCIK 1426800

Pharmaceutical preparations552 peers

Close
Oct 20, 2026 · +3.01%
Market cap
$431.61M
20.37M shares
Filings
904
$2.96M
Q3 2026+153.5% FY25 yoy
-$20.26M
Q3 2026N/M FY25 yoy
-$23.42M
Q3 2026N/M FY25 yoy
-$54.89M
Q3 2026derivedN/M FY25 yoy
-$0.93
Q3 2026N/M FY25 yoy
$29.07M
Q3 2026+52.4% FY25 yoy
$431.61M
—
6.4×
1.4×
-9.42%
—

Twelve months to Sep 30, 2026 · derived

Price

$21.1931.30%$9.65past year
Oct 20, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$72.30MFY 2025
$79.11M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$72,303,000reported
FY 20242024-12-31$28,520,000reported
FY 20232023-12-31$7,163,000reported
FY 20222022-12-31$0reported
FY 20212021-12-31$6,254,000reported
FY 20202020-12-31$79,105,000reported
FY 20192019-12-31$15,963,000reported
FY 20182018-12-31$14,804,000reported
FY 20172017-12-31$9,019,000reported
FY 20162016-12-31$0reported

Pharmaceutical preparations

Assembly Biosciences, Inc. is the 114th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR